Vertex Pharmaceuticals Income from Continuous Operations 2010-2024 | VRTX
Vertex Pharmaceuticals income from continuous operations for the twelve months ending June 30, 2024 was $-0.490B, a 114.56% decline year-over-year.
- Vertex Pharmaceuticals annual income from continuous operations for 2023 was $3.62B, a 8.96% increase from 2022.
- Vertex Pharmaceuticals annual income from continuous operations for 2022 was $3.322B, a 41.84% increase from 2021.
- Vertex Pharmaceuticals annual income from continuous operations for 2021 was $2.342B, a 13.63% decline from 2020.